NCT07639775

Brief Summary

The goal of this clinical trial is to learn whether osteopathic manipulative treatment, or OMT, can reduce the need for tympanostomy tube surgery in children with recurrent or chronic otitis media who have been referred to an Ear, Nose, and Throat surgeon and are being considered for tympanostomy tube placement. The main question it aims to answer is: Can a standardized OMT protocol, given once weekly for 4 weeks before the final surgical decision, reduce the rate of tympanostomy tube surgery in pediatric patients with recurrent or chronic otitis media? Researchers will compare children who receive the standardized OMT protocol with children who receive a placebo/control manual treatment protocol to see whether OMT leads to a clinically meaningful reduction in the need for surgery. Participants will:

  • Attend 4 weekly study visits before their final ENT surgical decision.
  • Receive one of several assigned combinations of standardized OMT intervention procedures and control manual procedures. Each participant's assigned treatment sequence is determined by randomization.
  • Complete study-related assessments and questionnaires related to ear symptoms and quality of life.
  • Continue their planned ENT care, including follow-up evaluation with the ENT surgeon to determine whether tympanostomy tube surgery is still recommended.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
22mo left

Started Aug 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 10, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

June 10, 2026

Status Verified

June 1, 2026

Enrollment Period

1.8 years

First QC Date

June 2, 2026

Last Update Submit

June 6, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Final Surgical Decision

    Following the final intervention for any given participant, the ENT physician, in conjunction with the parent/guardian, will determine whether to proceed with tympanostomy tube placement, defer, or cancel based on clinical status. This decision constitutes the primary outcome of the study.

    At the time of the participant's pre-operative ENT visit, following all four study visits.

Secondary Outcomes (4)

  • Tympanometry Data

    Performed at the inital ENT consultation as standard of care, and again at the time of the pre-operative ENT visit.

  • Audiometry Data

    Performed at the inital ENT consultation as standard of care, and again at the time of the pre-operative ENT visit.

  • Otitis Media Quality of Life Survey (OM-6)

    This survey will be administered at Week 1, Week 3 (study midpoint) and within one week of the participant's pre-operative ENT appointment.

  • Pediatric Quality of Life Inventory (PedsQL)

    This survey will be administered at Week 1, Week 3 (study midpoint) and within one week of the participant's pre-operative ENT appointment.

Study Arms (4)

Distal Region OMT Only

PLACEBO COMPARATOR

Participants assigned to this group receive a double dose of the control osteopathic manipulative treatment (OMT) protocol.

Other: Control Osteopathic Manipulative Treatment (OMT) Protocol

Intermediate Group: Distal Region OMT then Targeted OMT

OTHER

Participants assigned to this group receive a combination of the control OMT protocol followed by the experimental OMT protocol.

Other: Experimental Osteopathic Manipulative Treatment (OMT) ProtocolOther: Control Osteopathic Manipulative Treatment (OMT) Protocol

Intermediate Group: Targeted OMT then Distal Region OMT

OTHER

Participants assigned to this group receive a combination of the experimental OMT protocol followed by the control OMT protocol.

Other: Experimental Osteopathic Manipulative Treatment (OMT) ProtocolOther: Control Osteopathic Manipulative Treatment (OMT) Protocol

Targeted OMT Only

EXPERIMENTAL

Participants assigned to this group receive a double dose of the experimental OMT protocol.

Other: Experimental Osteopathic Manipulative Treatment (OMT) Protocol

Interventions

The Experimental Intervention is a standardized OMT protocol targeting the head, neck, thoracic, and lymphatic regions, selected to address anatomic and physiologic factors implicated in eustachian tube function, middle ear ventilation, and lymphatic drainage. The protocol consists of widely taught, non-invasive osteopathic techniques delivered in a fixed sequence and duration.

Also known as: True Intervention
Intermediate Group: Distal Region OMT then Targeted OMTIntermediate Group: Targeted OMT then Distal Region OMTTargeted OMT Only

The Control Intervention is a protocol of genuine OMT applied to the Sacrum, Pelvis and Lower Extremity body regions plus standard of care. This Control Intervention is conceptualized as inert in the study population.

Distal Region OMT OnlyIntermediate Group: Distal Region OMT then Targeted OMTIntermediate Group: Targeted OMT then Distal Region OMT

Eligibility Criteria

Age6 Months - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 6 months to less than 7 years. (All participants)
  • Referred to an otolaryngologist (ENT) for evaluation of chronic otitis media with effusion (OME) or recurrent acute otitis media (AOM). (All participants)
  • Planned for tympanostomy tube placement (unilateral or bilateral) pending surgical decision. (All participants)
  • At least 5 weeks between enrollment and anticipated surgical decision point. (All participants)

You may not qualify if:

  • Congenital or developmental conditions associated with increased otitis media risk, including but not limited to Down syndrome, cleft palate, or other craniofacial abnormalities. (All participants)
  • History of prior tympanostomy tube placement or current tympanostomy tubes in place. (All participants)
  • History of tympanic membrane perforation. (All participants)
  • Presence of preauricular pits. (All participants)
  • Patients requiring urgent or expedited surgical intervention, as determined by the treating ENT physician. (All participants)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Blue Ridge Ear, Nose and Throat

Lynchburg, Virginia, 24501, United States

Location

Collaborative Healthplex

Lynchburg, Virginia, 24502, United States

Location

Related Publications (3)

  • Carreiro JE. An Osteopathic Approach to Children. 2nd ed. Churchill Livingstone; 2009.

    BACKGROUND
  • Kim CH, McCray LR, Nguyen SA, Shermetaro C, Robbins WK. Use of osteopathic manipulation techniques for management of acute otitis media in pediatric patients: a scoping review. Eur Arch Otorhinolaryngol. 2025 Nov;282(11):5519-5528. doi: 10.1007/s00405-025-09492-9. Epub 2025 Jun 6.

    PMID: 40481343BACKGROUND
  • Mills MV, Henley CE, Barnes LL, Carreiro JE, Degenhardt BF. The use of osteopathic manipulative treatment as adjuvant therapy in children with recurrent acute otitis media. Arch Pediatr Adolesc Med. 2003 Sep;157(9):861-6. doi: 10.1001/archpedi.157.9.861.

    PMID: 12963590BACKGROUND

MeSH Terms

Conditions

Otitis MediaOtitis Media with Effusion

Interventions

Clinical Protocols

Condition Hierarchy (Ancestors)

OtitisEar DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsEpidemiologic Study CharacteristicsHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and Evaluation

Central Study Contacts

Mark D Unger, D.O., M.S.

CONTACT

Sarah Vidal, B.S.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Fellow

Study Record Dates

First Submitted

June 2, 2026

First Posted

June 10, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

May 31, 2028

Study Completion (Estimated)

May 31, 2028

Last Updated

June 10, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Only designated research personnel will have access to identifiable participant data. For the purposes of data analysis, the information will be de-identified.

Locations